ADVANCED HEALTH LIMITED - Trading statement

Trading statement

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049        JSE Code: AVL

TRADING STATEMENT

In terms of paragraph 3.4(b)(i) of the Listings Requirements of the Johannesburg Stock Exchange,
listed companies are required to publish a trading statement as soon as they become reasonably
certain that the financial results for the next period to be reported on will be more than 20%
different from those of the previous corresponding period or from a profit forecast previously
provided to the market in relation to such period.

Shareholders are advised that Advanced Health expects to report that net profit after taxation
attributable to the parent, as per the financial results for the year ended 30 June 2015, has
increased to R15.854 million compared to R7.470 million for the year ended 30 June 2014. The
prospectus issued by the company on 31 March 2014 showed a profit forecast of R14.111 million.

However due to the increased number of shares in issue pursuant to the listing, the earnings per
share will be 7.15 cents for the year ended 30 June 2015 compared to earnings per share of 6.44
cents for the year ended 30 June 2014, representing an increase of 11.02%. The forecast earnings
was 6.71 cents per share, representing an increase of 6.56%.

Headline earnings for the year will be R7.232 million compared to the prior year of R7.740 and the
forecast of R14.111 million. Accordingly, the headline earnings per share will be 3.26 cents for the
year ended 30 June 2015 compared to headline earnings per share of 6.44 cents for the year
ended 30 June 2014, being a decline of 49.38%. The forecast headline earnings was 6.71 cents per
share, representing a decrease of 51.41%.

The reasons for headline earnings being lower than anticipated are as follows:

-      The impact of the strengthening of the rand against the Australian dollar, with
       approximately 87% of the group’s revenue coming from the Australian operations with an
       average exchange rate of R9.55 to the Australian Dollar. The number of patients and
       revenue per patient was slightly ahead of the profit forecast. However, the forecast
       assumed an exchange rate of R10.82 to the Australian Dollar.
-      Higher costs being absorbed with the development of new clinics in both South Africa and
       Australia.
-      The weighted average number of shares increased to 221 614 801 shares from 120 272 415
       shares in the prior year. The increase in the weighted average number of shares for the
       year ended 30 June 2015 is a result of the shares being weighted for the entire year as well
       as the issue of new shares for the acquisition of five companies where day clinics are being
       developed.

The financial information on which this trading statement is based has not been reviewed and
reported on by the company’s auditors.

The company’s results announcement for the year ended 30 June 2015 is expected to be
published on or about 1 September 2015.


27 August 2015
Johannesburg

Designated Advisor
Arbor Capital Sponsors Proprietary Limited

Date: 27/08/2015 09:26:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.